Core Viewpoint - Yonghe Intelligent Control (002795) has repeatedly attempted to sell its subsidiary, Tai Xing Pu Le, with the initial asking price of 30.49 million yuan dropping to just 1 yuan, and the highest bid in the latest round being only 101 yuan [1][2]. Group 1: Company Financial Performance - Yonghe Intelligent Control has faced significant financial challenges, reporting net losses of 27 million yuan in 2022, 156 million yuan in 2023, and projected losses of 297 million yuan in 2024 [2]. - For the first three quarters of the current year, the company reported revenue of 582 million yuan, a year-on-year decrease of 7.25%, and a reduction in net losses from 76.2 million yuan to 60.46 million yuan [2]. - The company’s subsidiary, Tai Xing Pu Le, has been struggling financially, with total assets of 300 million yuan and liabilities reaching 561 million yuan, indicating insolvency [3]. Group 2: Asset Disposal Attempts - The company has made six attempts to sell its 51% stake in Tai Xing Pu Le, with the initial listing price set at 30.49 million yuan, which was progressively lowered through multiple rounds of bidding [1]. - The sixth round of bidding saw the minimum price drop to 1 yuan, with a confirmed potential buyer offering 101 yuan, pending approval from other shareholders [1]. Group 3: Business Operations and Strategy - Yonghe Intelligent Control's main business areas include plumbing valves, cancer precision radiation therapy, and photovoltaic cells, with a focus on brass valves [2][4]. - The company’s strategy to enter the photovoltaic battery sector through an investment of 31.22 million yuan for a 51% stake in Tai Xing Pu Le has not yielded the expected results, leading to asset divestiture as a means of survival [2][3].

Core Viewpoint - Yonghe Intelligent Control is struggling to sell its assets, as evidenced by multiple unsuccessful attempts to transfer its subsidiaries, leading to significant price reductions in the latest offerings [1][2][3]. Group 1: Asset Sales - Yonghe Intelligent Control announced the fifth attempt to publicly transfer 51% of its subsidiary, Puluo New Energy Technology (Taixing) Co., Ltd., after four previous attempts failed to attract any bidders. The starting price for this attempt has been reduced by 80% to 609.80 million yuan [2]. - The company is also attempting to transfer 100% of its subsidiary, Kunming Medical Oncology Hospital Co., Ltd., for the third time, with the price lowered by 40% to 2155.662 million yuan after two unsuccessful attempts [3]. Group 2: Financial Performance - Yonghe Intelligent Control has faced financial difficulties, reporting net losses of 0.27 billion yuan, 1.56 billion yuan, and 2.97 billion yuan for the years 2022 to 2024, respectively [4]. - In the third quarter of 2025, the company reported a revenue of 582 million yuan, a year-on-year decrease of 7.25%. The net loss for the same period was 60.46 million yuan, a slight improvement from the previous year's loss of 76.20 million yuan [6].

Core Viewpoint - Yonghe Intelligent Control Co., Ltd. is divesting all its investments in private oncology hospitals, marking a complete exit from the healthcare sector due to ongoing financial struggles and poor performance of its medical assets [2][3][5]. Group 1: Divestment Details - Yonghe Intelligent Control has initiated the public transfer of 100% equity in its wholly-owned subsidiary, Kunming Medical Oncology Hospital, with a starting price of no less than 35.93 million yuan [3][4]. - This divestment is part of a broader strategy, as Yonghe has already attempted to sell its stakes in three other oncology hospitals since 2020, including Dazhou Medical Oncology Hospital, Liangshan High-tech Oncology Hospital, and Xi'an Medical Oncology Hospital [3][4]. - The financial performance of Kunming Medical has been poor, with revenues of 11.58 million yuan and a net loss of 6.59 million yuan for the first seven months of 2025, contributing to Yonghe's decision to sell [3][6]. Group 2: Financial Performance - Yonghe Intelligent Control's main business includes fluid control products, oncology precision radiation treatment, and photovoltaic battery production. The company reported a revenue of 1.01 billion yuan in 2021, marking a 55.71% increase [5]. - However, the company's financial situation deteriorated significantly from 2022 to 2024, with revenues declining from 990 million yuan in 2022 to 823 million yuan in 2024, and net losses increasing from 26.19 million yuan to 297 million yuan during the same period [6]. - The decline in performance is attributed to reduced income from the valve and fitting business, lower product gross margins, and high depreciation and labor costs [6][7]. Group 3: Strategic Shift - Following the divestment of its medical assets, Yonghe Intelligent Control is expected to refocus on its core business operations. The company has not yet communicated its future strategic direction or potential new growth areas [7].

Core Viewpoint - Yonghe Intelligent Control is facing significant challenges in asset divestiture and ongoing financial losses, indicating a deteriorating business situation and lack of investor interest in its assets [1][2][3]. Group 1: Asset Transfer Attempts - Yonghe Intelligent Control announced the public transfer of 51% equity in Taixing Pule and all debts owed by Taixing Pule, with an initial listing price of RMB 30.49 million, but failed to attract any interested buyers [1][3]. - Following the lack of interest, the company plans a second round of asset transfer at a reduced price of RMB 24.39 million, reflecting a 20% decrease from the initial price [1][3]. - The company's previous attempt to transfer shares held by its actual controller was also unsuccessful, as the buyer failed to make the required payment, rendering the agreement void [1][9]. Group 2: Financial Performance - Yonghe Intelligent Control has experienced a continuous decline in revenue since 2022, with reported revenues of RMB 9.90 billion, RMB 9.48 billion, and RMB 8.23 billion for the years 2022, 2023, and 2024 respectively, showing year-on-year declines of -1.86%, -4.19%, and -13.19% [2][7]. - The company reported net losses of RMB 261.87 million, RMB 1.56 billion, and RMB 2.97 billion for the same years, with losses increasing significantly year-on-year [2][7]. - For the first three quarters of 2025, Yonghe Intelligent Control reported revenues of RMB 5.82 billion, a decrease of 7.25% year-on-year, and a net loss of RMB 60.46 million, although this loss was less than the previous year's figure [8]. Group 3: Company Background and Business Operations - Yonghe Intelligent Control's main business includes water and heating valve fittings, tumor precision radiation treatment, and photovoltaic cell operations, with a focus on brass and copper products [7]. - The company acquired a 51% stake in Taixing Pule in late 2022 for RMB 31.22 million, aiming to enter the photovoltaic cell industry, but has since struggled with the performance of this investment [5][8]. - As of May 31, 2025, Taixing Pule reported a net asset value of -RMB 304 million and a debt of RMB 185 million, leading to a high debt-to-asset ratio of 211% [4].